Breast reconstruction (BR) rates increased from 2005 to 2012, then stabilized from 2013 to 2017, according to a study ...

Patients with early-stage, node-negative, hormone receptor (HR)-positive, HER2- negative breast cancer who have a high risk ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

Therapeutics highlights the infiltration of cancer fighting immune cells into tumors, using leading CD8 ImmunoPET imaging ...

Raven-Symoné recently shared a deeply personal experience about undergoing breast reduction surgery at the age of 15.

This week, the Henry B. Gonzalez Convention Center is where leading doctors from all over have gathered to share research and ...

Raven-Symoné recalled having her first breast reduction when she was just 15 years old. While speaking on her podcast Tea ...

Raven-Symoné recalls being pushed to alter her body in order to get a television show at the tender age of 15.

While under competitive pressure from Novartis and Eli Lilly, Pfizer can tally up a unique trial win for its Ibrance in a ...

The median time from breast cancer diagnosis to surgery was 0.8 years for risk-reducing mastectomies and three years for risk ...

Receiving immediate surgery was associated with a reduction in local recurrence of breast cancer in elderly patients versus delaying surgery.

Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction ...